EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A qualitative evaluation of barriers and facilitators to a large-scale antithrombotic stewardship intervention in the United States Veterans Healthcare system

Jacob E Kurlander, Claire H Robinson, David Parra, Lacey Evans, Von Moore, Geoffrey D Barnes, Allison A Ranusch, Jeremy B Sussman

International Journal of Clinical Pharmacy · 2025-12 · 47 (6) · 1710-1719

DOI: 10.1007/s11096-025-01922-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Pharmacy, online erschienen am 04.06.2025. Verfasst von Jacob E Kurlander und 7 weiteren Autor:innen. Beteiligte Einrichtung: VA Ann Arbor Healthcare System Center for Clinical Management Research, PO Box 130170, Ann Arbor, MI, 48113-0170, USA. jkurland@med.umich.edu. Hauptthemen laut MEDLINE: Pharmacists, Platelet Aggregation Inhibitors, Fibrinolytic Agents, Anticoagulants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Quality Enhancement Research Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The combined use of antiplatelet medications with direct oral anticoagulants increases patients’ risk of hemorrhage. In 2021, a multistate network of Veterans Affairs medical centers in the United States deployed a successful multicomponent stewardship initiative to reduce inappropriate anticoagulant-antiplatelet therapy.

Aim

Identify barriers, facilitators, and potential adaptations of the initiative to guide broader dissemination.

Methods

Clinical pharmacists and pharmacist managers were invited to participate in semi-structured interviews about their experiences with the initiative. Interviews were transcribed. Thematic analysis was informed by the Consolidated Framework for Implementation Research (CFIR).

Results

Fifteen interviews were completed (response rate 68%). The initiative was considered important and worth disseminating, and the addition of a visual alert to flag potential deprescribing candidates on an anticoagulation population management dashboard was considered especially beneficial. Three primary themes were identified using the CFIR. First, pharmacists often encountered barriers to coordination across specialties, with some clinicians unconvinced of the clinical evidence favoring antiplatelet deprescribing; breaking down these clinical silos, through targeted education and identifying meaningful clinician champions, is essential to increasing success of this initiative. Second, pharmacists sought clarification about how their deprescribing efforts, a relatively new activity, would be accounted for in performance evaluations, and how clinics would meet increased staffing needs. Third, adaptability of the initiative to local context was considered valuable.

Conclusion

As part of a multicomponent oral anticoagulant-antiplatelet stewardship initiative, preventing clinical silos, clarifying expectations around performance and staffing, and permitting adaptations to local context are important to maximizing impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacistsPlatelet Aggregation InhibitorsFibrinolytic AgentsAnticoagulantsVeterans Health ServicesHumansUnited StatesQualitative ResearchUnited States Department of Veterans AffairsDeprescriptions

Stichwörter der Autor:innen

AnticoagulantsAntiplateletClinical pharmacistsDeprescribingImplementation

Substanzen

Platelet Aggregation InhibitorsFibrinolytic AgentsAnticoagulants

Autor:innen und Institutionen

  • VA Ann Arbor Healthcare System Center for Clinical Management Research, PO Box 130170, Ann Arbor, MI, 48113-0170, USA. jkurland@med.umich.edu.
  • Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. jkurland@med.umich.edu.
  • VA Ann Arbor Healthcare System Center for Clinical Management Research, PO Box 130170, Ann Arbor, MI, 48113-0170, USA.
  • Department of Veterans Affairs, Pharmacy Benefits Management, Veterans Integrated Service Network 8, Tampa, FL, USA.
  • Pharmacy Benefits Management Services, VA Center for Medication Safety, Hines, IL, USA.
  • Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

Förderung

  • Quality Enhancement Research Initiative

Zitieren

APA

Kurlander, J. E., Robinson, C. H., Parra, D., Evans, L., Moore, V., Barnes, G. D., Ranusch, A. A., & Sussman, J. B. (2025). A qualitative evaluation of barriers and facilitators to a large-scale antithrombotic stewardship intervention in the United States Veterans Healthcare system. International Journal of Clinical Pharmacy, 47(6), 1710-1719. https://doi.org/10.1007/s11096-025-01922-2

Vancouver

Kurlander JE, Robinson CH, Parra D, Evans L, Moore V, Barnes GD, et al. A qualitative evaluation of barriers and facilitators to a large-scale antithrombotic stewardship intervention in the United States Veterans Healthcare system. International Journal of Clinical Pharmacy. 2025;47(6):1710-1719. doi:10.1007/s11096-025-01922-2

BibTeX
@article{Kurlander2025,
  author = {Kurlander, Jacob E and Robinson, Claire H and Parra, David and Evans, Lacey and Moore, Von and Barnes, Geoffrey D and Ranusch, Allison A and Sussman, Jeremy B},
  title = {A qualitative evaluation of barriers and facilitators to a large-scale antithrombotic stewardship intervention in the United States Veterans Healthcare system},
  journal = {International Journal of Clinical Pharmacy},
  year = {2025},
  volume = {47},
  number = {6},
  pages = {1710--1719},
  doi = {10.1007/s11096-025-01922-2}
}
Kostenlos starten →